Evidence map›Paper›PMID 31667199›Full record

ArticleOpen forum infectious diseases2019

Occupational Exposure to the Ugandan Research Strain (MR766) of Zika Virus.

Paola N Lichtenberger, Michael J Ricciardi, Dalhila Solorzano, Patricia Raccamarich, Ana Leda, Mark Sharkey, David I Watkins, Hana El Sahly, Nadine Rouphael, Mark J Mulligan and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Paola N LichtenbergerDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Michael J RicciardiDepartment of Pathology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Dalhila SolorzanoDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Patricia RaccamarichDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Ana LedaDepartment of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA.
Mark SharkeyDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
David I WatkinsDepartment of Pathology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Hana El SahlyDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Nadine RouphaelDepartment of Medicine, Emory University, Atlanta, Georgia, USA.
Mark J MulliganNew York University Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, New York University School of Medicine, New York, New York, USA.
Susanne Doblecki-LewisDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Mario StevensonDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Maria L AlcaideDepartment of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
University of Miami · USBaylor College of Medicine · USEmory University · USNew York University · US

Funding

ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)U01AI047996 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GOEPFERT, PAUL A. · 2000 to 2006
$8.4M
NIAID NIH HHS U01 AI047996
6 · The paper itself

Abstract

A laboratory worker suffered an accidental needle-stick resulting in an exposure to the Ugandan strain (MR766) of Zika virus, which has rarely been studied in humans. We report the clinical presentation and outcomes, molecular and serological diagnostic results, and antibody response.

Indexed as

antibody responsesoccupational exposureviral persistenceZIKV

Identifiers

PMID31667199
PMCPMC6814281
OpenAlexW2981998400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.